US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist

0.9637
-0.0163-1.66%

Close Dec 20 16:00 ET

0.9901
+0.0264+2.74%

Post 19:36 ET

121.23MMarket Cap-4.59P/E (TTM)

Atossa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atossa Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Atossa Therapeutics Earnings Reports

Atossa Therapeutics | 8-K: Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12 12:18 ET

Atossa Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12 12:18 ET

Atossa Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 09:10 ET

Atossa Therapeutics | 8-K: Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12 09:05 ET

Analyst Rating

Updated: Dec 10, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall